Similar articles

• [Oral contraceptive-induced liver tumors and pregnancy].

  Wilhelm C, Quaas L, Zahradnik HP, Breckwoldt M. Wilhelm C, et al. Geburtshilfe Frauenheilkd. 1990 Oct;50(10):806-9. doi: 10.1055/s-2008-1026368. Geburtshilfe Frauenheilkd. 1990. PMID: 1962751 German.
• [Epidemiology of hormone dependent malignant tumors--ovulation inhibitors and liver tumors].

  Bergmann M, Jorke D, Machnik G, Neupert A, Reinhardt M. Bergmann M, et al. Dtsch Z Verdau Stoffwechselkr. 1986;46(1):30-8. Dtsch Z Verdau Stoffwechselkr. 1986. PMID: 3013581 German.
• Maternal death resulting from rupture of liver adenoma associated with oral contraceptives.

  Kent DR, Nissen ED, Nissen SE, Chambers C. Kent DR, et al. Obstet Gynecol. 1977 Jul;50(1 Suppl):5s-6s. Obstet Gynecol. 1977. PMID: 195241 No abstract available.
• Hepatic tumors: possible relationship to use of oral contraceptives.

  Klatskin G. Klatskin G. Gastroenterology. 1977 Aug;73(2):386-94. Gastroenterology. 1977. PMID: 194813 Review. No abstract available.
• [A further case of hepatocytic adenoma following oestrogenprogestogen treatment. Review of the literature (author's transl)].

  Grandjean JP, Vignal J, Seffert P, Mestrallet G, Beurlet J, Quiviger P. Grandjean JP, et al. Sem Hop. 1980 Feb 18-25;56(7-8):383-92. Sem Hop. 1980. PMID: 6246638 Review. French.